This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Dendreon, Heinz: Analysts' New Ratings

Stocks in this article: EXPR GIS HNZ VRUS DV CBRL ASCA DNDN

Editor's Note: Green and red arrows refer to intraday stock price movement.


Ameristar Casinos (ASCA) downgraded at Goldman from Neutral to Sell. Stock is up 44% year-to-date and the company is facing increased competition. $20 price target.

Cracker Barrel (CBRL) downgraded at Argus from Buy to Hold. Company is seeing lower sales.

Cracker Barrel downgraded at BofA/Merrill from Buy to Underperform. Company is facing growth headwinds. $44 price target.

Dendreon (DNDN) rated new Buy at Goldman Sachs. $50 price target. Provenge is a potential blockbuster drug.

Devry (DV) upgraded at BofA/Merrill to Buy. Gainful employment regulation was softened. $68 price target.

Education Management (EDMC) upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. $24 price target. DOE has lessened its regulations on the for-profit group.

Express (EXPR) rated new Buy at Brean Murray. $26 price target. Company can continue to expand margins, despite rising input costs.

General Mills (GIS) downgraded at UBS from Buy to Neutral. Valuation call, based on a $41 price target.

Heinz (HNZ) upgraded at UBS from Neutral to Buy. $62 price target. Company can deliver above-consensus growth over the next several quarters.

Pharmasset (VRUS) rated new Buy at Brean Murray. $174 price target. Company is a market leader in what should become a top hepatitis C therapy.

End of report.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs